Login

ImmuPharma "absolutely delighted" to push on with new clinical trial -Tim McCarthy, FCCA, MBA - Chief Executive Officer, ImmuPharma 00:00:00

Share On Facebook Share On Twitter

Tim has 40 years’ international senior level business experience in high growth biotech, healthcare and technology companies. He is also Chairman of Incanthera plc and 4basebio plc. Tim was formerly CEO and CFO of a number of UK public listed and private companies including, including Alizyme plc and Peptide Therapeutics Group plc, and has a core understanding of AIM and its regulatory processes.

Recent Videos

00:10:00
Thomas Olin Highlights Kancera’s Latest Advances and Strategic Focus | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Pablo Pereiro Discusses Squirrel Media’s 63% Profit Growth and 14.7% Stock Surge | Pablo Pereiro , CEO , Squirrel Media SA.
00:10:00
Steve Oliver of musicMagpie Discusses Circular Economy and Company's Growth Strategy | Steve Oliver , CEO , musicMagpie PLC.
00:10:00
Revolutionizing Healing with Naturally Derived Psychedelics | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
SMC Global Securities Launches New Office at Bahu Plaza, Jammu, to Promote Share Market Investments | Ajay Garg , CEO , SMC Global Securities Ltd.
00:10:00
Exploring Demoralization Syndrome Treatment with Filament Health’s Psilocybin Trials | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
BioInvent CEO Explores Portfolio Strategy and Upcoming Breakthroughs | Dr. Martin Welschof, CEO , BioInvent International AB.
00:10:00
Piotr Figarski Discusses Image Power's 2022 Results and Future Trends | Piotr Figarski, Vice President , Image Power SA.
00:10:00
Pablo Pereiro and María Bonaria Fois Discuss Squirrel Media's Strategic Acquisition of Mondo TV Studios | Pablo Pereiro , CEO , Squirrel Media SA.
00:10:00
Lexington Gold Set to List on London AIM Exchange After Reverse Takeover | Dr. Bernard Olivier, CEO , Lexington Gold Ltd.
00:10:00
Thomas Olin, CEO of Kancera AB, Discusses Strategic Advances in Biopharma Innovation | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Leading the Charge in the Psychedelic Movement with Filament Health | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
Pini Mandel on the Power of Dynamic Pricing to Boost Retail KPIs and Customer Satisfaction | Pini Mandel , CEO , Quicklizard Ltd.
00:10:00
Jean Michel Ng Tseung, New CEO of MCB Group, Shares Vision for a Sustainable Future | Jean Michel Ng Tseung , CEO , MCB Group Ltd.
00:10:00
Viktor Garmiani Unveils Candles Scandinavia’s Q4 Report Highlights | Viktor Garmiani, CEO , Candles Scandinavia AB.
00:10:00
Squirrel Media's Record-Breaking Year: CEO Pablo Pereiro Discusses Key Strategies and Global Expansion | Pablo Pereiro , CEO , Squirrel Media SA.

Suggestions

00:10:00
Newcrest Deal Secures BC Gold: Newmont CEO Tom Palmer Touts Fabulous District | Tom Palmer - President and Chief Executive Officer of Newmont Corporation
00:10:00
Partners with exceptional entrepreneurs starting at the earliest stages of the climb|Erica Brescia,Managing Director,Redpoint
00:10:00
Investing and Real Estate Insights with Kevin Mattson | Kevin Mattson, Managing Partner of Northeast Asset Management
00:00:00
Saniona President and CEO Rami Levin provides an overview of near-term milestones for key clinical programs - Rami Levin, CEO, Saniona
00:10:00
Tim Fitzpatrick, CEO and Co-Founder of IKONA Health, discusses their innovative kidney education platform designed for improved learning outcomes.
00:10:00
supporting each funding round and bridging any gaps in between|Avidan Ross,Founding Partner,Root Ventures
00:10:00
2024 Market Insights: January Update
00:10:00
Cromwell European REIT CEO on Strategic Pivot to Logistics and its Impact in Europe | Simon Garing , CEO , Cromwell European Real Estate Investment Trust .
00:10:00
Collateralized Reinsurance & Retro: Enhancing Consistency and Coverage
00:10:00
Advance Auto Parts CEO Tom Greco Addresses Q3 Earnings Miss and Shares Strategy for Margin Expansion | Tom Greco, CEO, Advance Auto Parts.
00:10:00
GV originated as an independent venture capital firm for innovative founders|Andy Wheeler,General Partner,GV
00:10:00
Radiopharmaceutical Innovations in Cancer Diagnosis |Dr Alan Taylor , Executive Chairma, Clarity Pharmaceuticals Ltd.

© 2017 - Townhall + Tv